DFCI: 16-237 Ph1b PVX-410 in SMM (Multiple Myeloma) - Clinical Trial
What is the Purpose of this Study?
We are doing this study to learn how safe and comfortable PVX-410 in combination with CC-96241 (with and without lenalidomide) is for patients with smoldering multiple myeloma (SMM).
Smoldering Multiple Myeloma
Patients determined to be eligible, based on Screening assessments, will be enrolled in the study.
Who Can Participate in the Study?
Diagnosis of Smoldering Multiple Myeloma
What is Involved?
First, we will ask for a blood sample to determine eligibility.
If still eligible you will be asked to:
-Take the study drug as directed
-Complete blood draws
-Give a bone marrow sample
-A body scan (MRI, CT, X-ray)